Evidence map›Paper›PMID 30925932›Full record

ArticleMicrobiome2019

Comparative genomics of human Lactobacillus crispatus isolates reveals genes for glycosylation and glycogen degradation: implications for in vivo dominance of the vaginal microbiota.

Charlotte van der Veer, Rosanne Y Hertzberger, Sylvia M Bruisten, Hanne L P Tytgat, Jorne Swanenburg, Alie de Kat Angelino-Bart, Frank Schuren, Douwe Molenaar, Gregor Reid, Henry de Vries and 1 more

Open access · goldAbstract read
In one paragraph

Article in Microbiome, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed, 1 pooled it
17.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 1 synthesis or guideline pooled it, 165 citations in OpenAlex.

  1. The Effect of Exogenous Sex Steroids on the Vaginal Microbiota: A Systematic Review.Frontiers in cellular and infection microbiology · 2021
    Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Orally ingestedFrontiers in microbiology · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Pangenome analysis ofMicrobiology spectrum · 2025
    Article
  18. Article
  19. Article
  20. Increased vaginalmSystems · 2025
    Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Charlotte van der VeerDepartment of Infectious Diseases, Public Health Service, GGD, Amsterdam, The Netherlands.
Rosanne Y HertzbergerDepartment of Molecular Cell Biology, Faculty of Science, O|2 Lab Building, VU University, De Boelelaan 1108, 1081 HZ, Amsterdam, The Netherlands.
Sylvia M BruistenDepartment of Infectious Diseases, Public Health Service, GGD, Amsterdam, The Netherlands.
Hanne L P TytgatInstitute of Microbiology, ETH Zürich, Zurich, Switzerland.
Jorne SwanenburgDepartment of Molecular Cell Biology, Faculty of Science, O|2 Lab Building, VU University, De Boelelaan 1108, 1081 HZ, Amsterdam, The Netherlands.
Alie de Kat Angelino-BartNetherlands Organization for Applied Scientific Research (TNO), Microbiology and Systems Biology, Zeist, The Netherlands.
Frank SchurenNetherlands Organization for Applied Scientific Research (TNO), Microbiology and Systems Biology, Zeist, The Netherlands.
Douwe MolenaarDepartment of Molecular Cell Biology, Faculty of Science, O|2 Lab Building, VU University, De Boelelaan 1108, 1081 HZ, Amsterdam, The Netherlands.
Gregor ReidCanadian R&D Centre for Human Microbiome and Probiotics, Lawson Health Research Institute, London, Canada.
Henry de VriesDepartment of Infectious Diseases, Public Health Service, GGD, Amsterdam, The Netherlands.
Remco KortDepartment of Molecular Cell Biology, Faculty of Science, O|2 Lab Building, VU University, De Boelelaan 1108, 1081 HZ, Amsterdam, The Netherlands. r.kort@vu.nl.ORCID 0000-0003-3674-598X
Netherlands Organisation for Applied Scientific Research · NLGGD Amsterdam · NLVrije Universiteit Amsterdam · NLETH Zurich · CHWestern University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA vaginal microbiota dominated by lactobacilli (particularly Lactobacillus crispatus) is associated with vaginal health, whereas a vaginal microbiota not dominated by lactobacilli is considered dysbiotic. Here we investigated whether L. crispatus strains isolated from the vaginal tract of women with Lactobacillus-dominated vaginal microbiota (LVM) are pheno- or genotypically distinct from L. crispatus strains isolated from vaginal samples with dysbiotic vaginal microbiota (DVM).

resultsWe studied 33 L. crispatus strains (n = 16 from LVM; n = 17 from DVM). Comparison of these two groups of strains showed that, although strain differences existed, both groups degraded various carbohydrates, produced similar amounts of organic acids, inhibited Neisseria gonorrhoeae growth, and did not produce biofilms. Comparative genomics analyses of 28 strains (n = 12 LVM; n = 16 DVM) revealed a novel, 3-fragmented glycosyltransferase gene that was more prevalent among strains isolated from DVM. Most L. crispatus strains showed growth on glycogen-supplemented growth media. Strains that showed less-efficient (n = 6) or no (n = 1) growth on glycogen all carried N-terminal deletions (respectively, 29 and 37 amino acid deletions) in a putative pullulanase type I protein. DISCUSSION: L. crispatus strains isolated from LVM were not phenotypically distinct from L. crispatus strains isolated from DVM; however, the finding that the latter were more likely to carry a 3-fragmented glycosyltransferase gene may indicate a role for cell surface glycoconjugates, which may shape vaginal microbiota-host interactions. Furthermore, the observation that variation in the pullulanase type I gene is associated with growth on glycogen discourages previous claims that L. crispatus cannot directly utilize glycogen.

Indexed as

Bacterial ProteinsDysbiosisFemaleGenome, BacterialGenomicsGlycogenGlycosylationGlycosyltransferasesHumansLactobacillus crispatusNeisseria gonorrhoeaePhenotypePhylogenySequence Analysis, DNAVaginaBacterial ProteinsGlycogenGlycosyltransferases

Identifiers

PMID30925932
PMCPMC6441167
OpenAlexW2896489310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.